Status:
COMPLETED
Role of Supermicrosurgical LVA for Lower Limb Lymphedema
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Lymphedema
Eligibility:
All Genders
20-100 years
Brief Summary
Vascularized lymph node flap transfer (VLNT) was believed to be the treatment of choice for moderate-to-severe lymphedema. Recent publications have supported the use of supermicrosurgical lymphaticove...
Eligibility Criteria
Inclusion
- From November 2014 to January 2019
- Lower limb lymphedema patients
Exclusion
- Patients who have had previous LVA, liposuction, or excisional therapy such as the Charles procedure were excluded.
Key Trial Info
Start Date :
August 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 19 2020
Estimated Enrollment :
131 Patients enrolled
Trial Details
Trial ID
NCT04698707
Start Date
August 28 2020
End Date
November 19 2020
Last Update
January 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 83301